WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> HIV and NCDs: Integrated Care for Better Health and Stronger Systems 22/06/2022 Katie Dain & Lobna Salem People are living with HIV for much longer thanks to greatly improved antiretroviral treatments. But they also are at disproportionately high risk for non-communicable diseases which affect everyone more as they age. Now is the time to tackle both in a more integrated way. The extraordinary advances in science over the past three decades that […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> HIV and NCDs: Integrated Care for Better Health and Stronger Systems 22/06/2022 Katie Dain & Lobna Salem People are living with HIV for much longer thanks to greatly improved antiretroviral treatments. But they also are at disproportionately high risk for non-communicable diseases which affect everyone more as they age. Now is the time to tackle both in a more integrated way. The extraordinary advances in science over the past three decades that […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> HIV and NCDs: Integrated Care for Better Health and Stronger Systems 22/06/2022 Katie Dain & Lobna Salem People are living with HIV for much longer thanks to greatly improved antiretroviral treatments. But they also are at disproportionately high risk for non-communicable diseases which affect everyone more as they age. Now is the time to tackle both in a more integrated way. The extraordinary advances in science over the past three decades that […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> HIV and NCDs: Integrated Care for Better Health and Stronger Systems 22/06/2022 Katie Dain & Lobna Salem People are living with HIV for much longer thanks to greatly improved antiretroviral treatments. But they also are at disproportionately high risk for non-communicable diseases which affect everyone more as they age. Now is the time to tackle both in a more integrated way. The extraordinary advances in science over the past three decades that […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> HIV and NCDs: Integrated Care for Better Health and Stronger Systems 22/06/2022 Katie Dain & Lobna Salem People are living with HIV for much longer thanks to greatly improved antiretroviral treatments. But they also are at disproportionately high risk for non-communicable diseases which affect everyone more as they age. Now is the time to tackle both in a more integrated way. The extraordinary advances in science over the past three decades that […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> HIV and NCDs: Integrated Care for Better Health and Stronger Systems 22/06/2022 Katie Dain & Lobna Salem People are living with HIV for much longer thanks to greatly improved antiretroviral treatments. But they also are at disproportionately high risk for non-communicable diseases which affect everyone more as they age. Now is the time to tackle both in a more integrated way. The extraordinary advances in science over the past three decades that […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> HIV and NCDs: Integrated Care for Better Health and Stronger Systems 22/06/2022 Katie Dain & Lobna Salem People are living with HIV for much longer thanks to greatly improved antiretroviral treatments. But they also are at disproportionately high risk for non-communicable diseases which affect everyone more as they age. Now is the time to tackle both in a more integrated way. The extraordinary advances in science over the past three decades that […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> HIV and NCDs: Integrated Care for Better Health and Stronger Systems 22/06/2022 Katie Dain & Lobna Salem People are living with HIV for much longer thanks to greatly improved antiretroviral treatments. But they also are at disproportionately high risk for non-communicable diseases which affect everyone more as they age. Now is the time to tackle both in a more integrated way. The extraordinary advances in science over the past three decades that […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> HIV and NCDs: Integrated Care for Better Health and Stronger Systems 22/06/2022 Katie Dain & Lobna Salem People are living with HIV for much longer thanks to greatly improved antiretroviral treatments. But they also are at disproportionately high risk for non-communicable diseases which affect everyone more as they age. Now is the time to tackle both in a more integrated way. The extraordinary advances in science over the past three decades that […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
HIV and NCDs: Integrated Care for Better Health and Stronger Systems 22/06/2022 Katie Dain & Lobna Salem People are living with HIV for much longer thanks to greatly improved antiretroviral treatments. But they also are at disproportionately high risk for non-communicable diseases which affect everyone more as they age. Now is the time to tackle both in a more integrated way. The extraordinary advances in science over the past three decades that […] Continue reading -> Posts navigation Older postsNewer posts